Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Perioperative Dexmedetomidine and Esketamine on Postoperative Quality of Recovery
NCT07308756Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jan 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, esketamine in postoperative recovery, sponsored by Peking University First Hospital. Started Jan 2026; status: recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
postoperative recovery
Beyond the preview
Go deeper on NCT07308756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07308756.